Amagen India Life Sciences
Letrozole (2.5mg)
LETONIK 2.5mg Tablet is used to treat breast cancer in post-menopausal women, either alone or with other treatments, and to stop the tumor from spreading to other parts of the body.
Tablet
LETONIK 2.5mg Tablet is an aromatase inhibitor that helps treat breast cancer in post-menopausal women. It works by decreasing the amount of estrogen produced in the body, which can slow down or stop the growth of some breast cancers that need estrogen to grow. It may be used alone or with other treatments, such as surgery or radiation.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. It may be taken with or without food, but it is better to take it at a fixed time.
LETONIK 2.5mg Tablet is an aromatase inhibitor that works by decreasing the amount of estrogen produced in the body. This decrease in estrogen can slow down or stop the growth of some breast cancers that need estrogen to grow.
You have been prescribed LETONIK 2.5mg Tablet for the treatment of breast cancer. It can be taken with or without food. Do not drive or do anything requiring concentration until you know how LETONIK 2.5mg Tablet affects you. It may cause increased sweating and hot flushes. Try to keep cool by wearing light and airy clothes. Your doctor may monitor your cholesterol level and bone mineral density (BMD) regularly as LETONIK 2.5mg Tablet can alter their levels. Do not take LETONIK 2.5mg Tablet if you are pregnant or breastfeeding
LETONIK 2.5mg Tablet is an aromatase inhibitor prescribed to treat hormone-sensitive breast cancer in postmenopausal women. It is used when other treatment options are not effective or no longer suitable for the patient's condition.
LETONIK 2.5mg Tablet works by inhibiting aromatase, an enzyme that converts testosterone into estrogen in the body. This reduces the amount of estrogen produced, which helps to slow down the growth and spread of breast cancer cells.
The duration of treatment with LETONIK 2.5mg Tablet depends on factors such as the stage and extent of the tumor, patient response to treatment, and individual medical circumstances. It is typically prescribed for a period of time following the initial diagnosis or progression of breast cancer. Your doctor will determine the appropriate course of treatment based on your specific needs.
It is important to consult with your doctor regarding the combination of these medications. While it's generally safe for patients on both medications, your doctor will need to assess any potential interactions or risks.
The risk of developing a cataract during treatment with LETONIK 2.5mg Tablet is uncommon but may occur in some individuals. If you experience blurred vision or eye irritation, it's crucial to seek immediate medical attention.
Hot flushes, which are associated with reduced estrogen levels and can result in sweating, may be reported as a side effect during treatment. This is a common consequence that usually diminishes over time.
Serious side effects of LETONIK 2.5mg Tablet can include stroke, angina, heart attack, blood clotting, cataracts, osteoporosis, and severe skin reactions. It's important to report any unusual or concerning symptoms to your doctor immediately.
This medication may cause thinning of the bones (osteoporosis) due to decreased estrogen levels in the body. Regular bone density monitoring is recommended by your doctor.
LETONIK 2.5mg Tablet is restricted for use in inducing ovulation in patients with anovulation (unusually low levels of estrogen) in infertile individuals.